S. Adámi

Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study

Jean‐Yves Reginster, Ego Seeman, M.C. de Vernejoul et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 1.1K citations · Full text

The Effect of Teriparatide [Human Parathyroid Hormone (1–34)] Therapy on Bone Density in Men With Osteoporosis

WH Scheele, S. Paul, S. Adámi et al. · Journal of Bone and Mineral Research · 2003 · 761 citations

The acute-phase response after bisphosphonate administration

S. Adámi, A K Bhalla, Romolo M. Dorizzi et al. · Calcified Tissue International · 1987 · 354 citations

Translational Medicine, Clinical Pharmacology, Pharmacotherapy +4

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

Reginster Jy, S. Adámi, Péter L. Lakatos et al. · Annals of the Rheumatic Diseases · 2005 · 329 citations · Full text

Bone Disease, Once-monthly Oral Ibandronate, Bone Health +8

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.

Thomas J. Schnitzer, Henry G. Bone, G Crepaldi et al. · PubMed · 2000 · 299 citations

Bone Disease, Bone Health, Alendronate 10 +12